Increased expression of glial cell line-derived neurotrophic factor (GDNF) in the brains of scrapie-infected mice

Neuroscience Letters

Volumn 410, Issue 3, 2006, Pages 178-182

  Lee, Yun Jung ^a   Jin, Jae Kwang ^a   Jeong, Byung Hoon ^a   Carp, Richard I ^b   Kim, Yong Sun ^a  

^a Hallym University   (South Korea)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Astrocyte; Glial cell line derived neurotrophic factor; Prion; Scrapie

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL LOSS; CONTROLLED STUDY; DEGENERATIVE DISEASE; HIPPOCAMPUS; IMMUNOREACTIVITY; MOUSE; NERVE CELL; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCRAPIE; SCRAPIE VIRUS; STATISTICAL SIGNIFICANCE; VIRUS INFECTION; VIRUS STRAIN;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; BRAIN; GENE EXPRESSION REGULATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCRAPIE; TIME FACTORS;

EID: 33751012139     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.09.090     Document Type: Article

References (40)

1. Abe K., and Hayashi T. Expression of glial cell line-derived neurotrophic factor gene in rat brain after transient MCA occlusion. Brain Res. 776 (1997) 230-234
2. Aguzzi A., and Weissmann C. Prions research: the next frontiers. Nature 389 (1997) 795-798
3. Arenas E., Trupp M., Akerud P., and Ibanez C.F. GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15 6 (1995) 1465-1473
4. Beck K.D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R.A., Rosenthal A., and Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373 (1995) 339-341
5. res propagation as early primary pathogenic event in prion disease. Brain Res. Bull. 68 (2006) 346-354
6. Budka H., Aguzzi A., Brown P., Brucher J.M., Bugiani O., Gullotta F., Haltia M., Hauw J.J., Ironside J.W., and Jellinger K. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol. 5 (1995) 459-466
7. Burbach G.J., Hellweg R., Haas C.A., Turco D.D., Deicke U., Abramowski D., Jucker M., Staufenbiel M., and Deller T. Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice. J. Neurosci. 24 (2004) 2421-2430
8. Carp R.I., Ye X., Kascsak R.J., and Rubenstein R. The nature of the scrapie agent. Biological characteristics of scrapie in different scrapie strain-host combinations. Ann. N.Y. Acad. Sci. 724 (1994) 221-234
9. Choi S.I., Ju W.K., Choi E.K., Kim J., Lea H.Z., Carp R.I., Wisniewski H.M., and Kim Y.S. Mitochondrial dysfunction induced by oxidative stress in the brains of hamsters infected with the 263K scrapie agent. Acta Neuropathol. 96 (1998) 279-286
10. Choi Y.G., Kim J.I., Lee H.P., Jin J.K., Choi E.K., Carp R.I., and Kim Y.S. Induction of heme oxygenase-1 in the brains of scrapie-infected mice. Neurosci. Lett. 289 (2000) 173-176
11. Cunningham C., Deacon R.M.J., Chan K., Boche D., Rawlins J.N.P., and Perry V.H. Neuropathologically distinct prion strains give rise to similar temporal profiles of behavioral defects. Neurobiol. Disease 18 (2005) 258-269
12. Durany N., Michel T., Kurt J., Cruz-Sanchez F.F., Cervos-Navarro J., and Riederer P. Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains. Int. J. Dev. Neurosci. 18 (2000) 807-813
13. Fraser H., and Dikinson A.G. Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation. J. Comp. Pathol. 83 (1973) 29-40
14. Gajusek D.C. Infectious amyloids: subacute spongiforms encephalopathies as transmissible cerebral amyloidoses. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Viology. 3rd ed. (1996), Lippincott-Laven Publishers, Philadelphia, PA 2851-2900
15. Henderson C.E., Pillips H.S., Pollock R.A., Davies A.M., Lemeulle C., Armnini M.P., Simpson L.C., Moffet B., Vanden R.A., Koliatsos V.E., and Rosenthal A. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266 (1994) 1062-1064
16. Ikeda T., Koo H., Xia Y.X., Ikenoue T., and Choi B.H. Bimodal up-regulation of glial cell line-derived neurotrophic factor (GDNF) in the neonatal rat brain following ischemic/hypoxic injury. Int. J. Dev. Neurosci. 20 (2002) 555-562
17. Ikeda T., Koo H., Xia Y.X., Ikenoue T., Han B., and Choi B.H. Glial cell line-derived neurotrophic factor protects against ischemic/hypoxia-induced brain injury in neonatal rat. Acta Neurophathol. (Berl.) 100 (2000) 161-167
18. Kim Y.S., Carp R.I., Callahan S., and Wisniewski H.M. Incubation periods and histopathological changes in mice injected stereotaxically in different brain areas with the 87V scrapie strain. Acta Neuropathol. (Berl.) 80 (1990) 388-392
19. Kim J.I., Ju W.K., Choi J.H., Kim J., Choi E.K., Carp R.I., Wisniewski H.M., and Kim Y.S. Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice. Mol. Brain Res. 73 (1999) 17-27
20. Kitagawa H., Hayashi T., Mitsumoto T., Koga N., Itoyama Y., and Abe K. Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral arteory occlusion in rats. Stroke 29 (1998) 1417-1422
21. Lee D.W., Shon H.O., Lim H.B., Lee Y.G., Kim Y.S., Carp R.I., and Wisniewski H.M. Alteration of free radical metabolism in the brain of mice infected with scrapie agent. Free Radic. Res. 30 (1999) 499-507
22. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., and Collin F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260 (1993) 1130-1132
23. Maruyama W., Nitta A., Shamoto-Nagai M., Hirata Y., Akao Y., Yodim M., Furukawa S., Nabeshima T., and Naoi M. N-Propargyl-1 (R)-aminoindan, rasagilin, increases glial cell line-derived neurotrophic factor (GDNF) in neuroblastoma SH-SY5Y cells through activation of NF-kB transcription factor. Neruochem. Int. 44 (2004) 393-400
24. Miyazaki H., Nagashima K., Okuma Y., and Nomura Y. Expression of glial cell line-derived neurotrophic factor induced by transient forebrain ischemia in rats. Brain Res. 922 (2001) 165-172
25. Miyazaki H., Okuma Y., Fuji Y., Nagashima K., and Nomura Y. Glial cell line-derived neurotrophic factor protects against delayed neuronal death after transient forebrain ischemia in rats. Neuroscience 89 (1999) 643-647
26. Mount H.T., Dean D.O., Alberch J., Dreyfus C.F., and Black I.B. Glial cell line-derived neurotrophic factor promotes the survival and morphologic differentiation of Purkinje cells. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 9092-9096
27. Oppenheim R.W., Houenou L.J., Johnson J.E., Lin L.H., Li L., Lo A.C., Newsome A.L., Prevette D.M., and Wang S. Developing moto neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373 (1995) 344-346
28. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 216 (1982) 795-798
29. Prusiner S.B. In: Fields B.M., Knipe D.M., and Howley P.M. (Eds). Virology. 3rd ed. (1996), Lippincott-Raven Publishers, Philadelphia, PA 2901-2950
30. Sakurai M., Hayashi T., Abe K., Yaginuma G., Meguro T., Itoyama Y., and Tabayashi K. Induction of glial cell line-derived neurotrophic factor and c-ret proto-oncogene-like immunoreactivity in rabbit spinal cord after transient ischemia. Neurosci. Lett. 276 (1999) 123-126
31. Siegel G.J., and Chauhan N.B. Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res. Rev. 33 (2000) 199-227
32. Scott J.R., and Fraser H. Degenerative hippocampal pathology in mice infected with scrapie. Acta Neuropathol. (Berl.) 65 (1984) 62-68
33. Tokumine J., Sugahara K., Kakinohana O., and Marsala M. The spinal GDNF level is increased after transient spinal cord ischemia in the rat. Acta Neurochir. 86 Suppl. (2003) 231-234
34. Tomac A., Linqvist E., Lin L.H., Ogren S.O., Young D., Hoffer B.J., and Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373 (1995) 335-339
35. Tsai T.H., Chen S.L., Chiang Y.H., Lin S.Z., Ma H.I., Kuo S.W., and Tsao Y.P. Recombinant adeno-associated virus vector expressing glial cell line-derived neurotrophic factor reduces ischemia-induced damage. Exp. Neurol. 166 (2000) 266-275
36. Wang Y., Lin S.Z., Chiou A.L., Williams L.R., and Hoffer B.J. Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. J. Neurosci. 17 (1997) 4341-4348
37. Wei G., Wu G., and Cao X. Dynamic expression of glial cell line-derived neurotrophic factor after cerebral ischemia. NeuroReport 11 (2000) 1177-1183
38. Williams L.R., Inouye G., Cummins V., and Pelleymounter M.A. Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: dose-response comparison to nerve growth factor and brain-derived neurotrophic factor. J. Pharmacol. Exp. Ther. 277 (1996) 1140-1151
39. Yagi T., Jikihara I., Fukumura M., Watabe K., Ohashi T., Eto Y., Hara M., and Meada M. Rescue of ischemic brain injury by adenoviral gene transfer of glial cell line-derived neurotrophic factor after transient global ischemia in gerbils. Brain Res. 885 (2000) 273-282
40. Zurn A.D., Baetge E.E., Hammang J.P., Tan S.A., and Aebischen P. Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurones. NeuroReport 6 (1994) 113-118